2018-2023 Global Parathyroid Disorders Market Report (Status and Outlook)

August 2018 | 119 pages | ID: 2323DB392C6EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Parathyroid Disorders market for 2018-2023.

Parathyroid disorders lead to abnormal levels of calcium in the blood that can cause brittle bones, kidney stones, fatigue, weakness, and other problems.
Patients with chronic kidney disease may develop secondary hyperparathyroidism with resultant chronic kidney disease-mineral and bone disorder. Hypoparathyroidism most often occurs after neck surgery; it can also be caused by autoimmune destruction of the glands and other less common problems. Evaluation of patients with abnormal serum calcium levels includes a history and physical examination; repeat measurement of serum calcium level; and measurement of creatinine, magnesium, vitamin D, and parathyroid hormone levels. The treatment for symptomatic primary hyperparathyroidism is parathyroidectomy. Management of asymptomatic primary hyperparathyroidism includes monitoring symptoms; serum calcium and creatinine levels; and bone mineral density. Patients with hypoparathyroidism require close monitoring and vitamin D (e.g., calcitriol) replacement.
Over the next five years, LPI(LP Information) projects that Parathyroid Disorders will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares and growth opportunities of Parathyroid Disorders market by product type, application, key companies and key regions.

To calculate the market size, LP Information considers value generated from the sales of the following segments:

Segmentation by product type:

• Simple Parathyroid Disorders
• Complex Parathyroid Disorders

Segmentation by application:

• Hospitals
• Clinics
• Diagnostic Centers
• Drug Stores
• Pharmacies

We can also provide the customized separate regional or country-level reports, for the following regions:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:

• Abbott Laboratories
• Alcon Laboratories
• Amgen
• Bayer Healthcare
• Becton, Dickinson and Company
• Eli Lilly
• Ethicon

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global Parathyroid Disorders market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Parathyroid Disorders market by identifying its various subsegments.
• Focuses on the key global Parathyroid Disorders players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Parathyroid Disorders with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the size of Parathyroid Disorders submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Parathyroid Disorders Market Size 2013-2023
  2.1.2 Parathyroid Disorders Market Size CAGR by Region
2.2 Parathyroid Disorders Segment by Type
  2.2.1 Simple Parathyroid Disorders
  2.2.2 Complex Parathyroid Disorders
2.3 Parathyroid Disorders Market Size by Type
  2.3.1 Global Parathyroid Disorders Market Size Market Share by Type (2013-2018)
  2.3.2 Global Parathyroid Disorders Market Size Growth Rate by Type (2013-2018)
2.4 Parathyroid Disorders Segment by Application
  2.4.1 Hospitals
  2.4.2 Clinics
  2.4.3 Diagnostic Centers
  2.4.4 Drug Stores
  2.4.5 Pharmacies
2.5 Parathyroid Disorders Market Size by Application
  2.5.1 Global Parathyroid Disorders Market Size Market Share by Application (2013-2018)
  2.5.2 Global Parathyroid Disorders Market Size Growth Rate by Application (2013-2018)

3 GLOBAL PARATHYROID DISORDERS BY PLAYERS

3.1 Global Parathyroid Disorders Market Size Market Share by Players
  3.1.1 Global Parathyroid Disorders Market Size by Players (2016-2018)
  3.1.2 Global Parathyroid Disorders Market Size Market Share by Players (2016-2018)
3.2 Global Parathyroid Disorders Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 PARATHYROID DISORDERS BY REGIONS

4.1 Parathyroid Disorders Market Size by Regions
4.2 Americas Parathyroid Disorders Market Size Growth
4.3 APAC Parathyroid Disorders Market Size Growth
4.4 Europe Parathyroid Disorders Market Size Growth
4.5 Middle East & Africa Parathyroid Disorders Market Size Growth

5 AMERICAS

5.1 Americas Parathyroid Disorders Market Size by Countries
5.2 Americas Parathyroid Disorders Market Size by Type
5.3 Americas Parathyroid Disorders Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Parathyroid Disorders Market Size by Countries
6.2 APAC Parathyroid Disorders Market Size by Type
6.3 APAC Parathyroid Disorders Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Parathyroid Disorders by Countries
7.2 Europe Parathyroid Disorders Market Size by Type
7.3 Europe Parathyroid Disorders Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Parathyroid Disorders by Countries
8.2 Middle East & Africa Parathyroid Disorders Market Size by Type
8.3 Middle East & Africa Parathyroid Disorders Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 GLOBAL PARATHYROID DISORDERS MARKET FORECAST

10.1 Global Parathyroid Disorders Market Size Forecast (2018-2023)
10.2 Global Parathyroid Disorders Forecast by Regions
  10.2.1 Global Parathyroid Disorders Forecast by Regions (2018-2023)
  10.2.2 Americas Market Forecast
  10.2.3 APAC Market Forecast
  10.2.4 Europe Market Forecast
  10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
  10.3.1 United States Market Forecast
  10.3.2 Canada Market Forecast
  10.3.3 Mexico Market Forecast
  10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
  10.4.1 China Market Forecast
  10.4.2 Japan Market Forecast
  10.4.3 Korea Market Forecast
  10.4.4 Southeast Asia Market Forecast
  10.4.5 India Market Forecast
  10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
  10.5.1 Germany Market Forecast
  10.5.2 France Market Forecast
  10.5.3 UK Market Forecast
  10.5.4 Italy Market Forecast
  10.5.5 Russia Market Forecast
  10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
  10.6.1 Egypt Market Forecast
  10.6.2 South Africa Market Forecast
  10.6.3 Israel Market Forecast
  10.6.4 Turkey Market Forecast
  10.6.5 GCC Countries Market Forecast
10.7 Global Parathyroid Disorders Forecast by Type
10.8 Global Parathyroid Disorders Forecast by Application

11 KEY PLAYERS ANALYSIS

11.1 Abbott Laboratories
  11.1.1 Company Details
  11.1.2 Parathyroid Disorders Product Offered
  11.1.3 Abbott Laboratories Parathyroid Disorders Revenue, Gross Margin and Market Share (2016-2018)
  11.1.4 Main Business Overview
  11.1.5 Abbott Laboratories News
11.2 Alcon Laboratories
  11.2.1 Company Details
  11.2.2 Parathyroid Disorders Product Offered
  11.2.3 Alcon Laboratories Parathyroid Disorders Revenue, Gross Margin and Market Share (2016-2018)
  11.2.4 Main Business Overview
  11.2.5 Alcon Laboratories News
11.3 Amgen
  11.3.1 Company Details
  11.3.2 Parathyroid Disorders Product Offered
  11.3.3 Amgen Parathyroid Disorders Revenue, Gross Margin and Market Share (2016-2018)
  11.3.4 Main Business Overview
  11.3.5 Amgen News
11.4 Bayer Healthcare
  11.4.1 Company Details
  11.4.2 Parathyroid Disorders Product Offered
  11.4.3 Bayer Healthcare Parathyroid Disorders Revenue, Gross Margin and Market Share (2016-2018)
  11.4.4 Main Business Overview
  11.4.5 Bayer Healthcare News
11.5 Becton, Dickinson and Company
  11.5.1 Company Details
  11.5.2 Parathyroid Disorders Product Offered
  11.5.3 Becton, Dickinson and Company Parathyroid Disorders Revenue, Gross Margin and Market Share (2016-2018)
  11.5.4 Main Business Overview
  11.5.5 Becton, Dickinson and Company News
11.6 Eli Lilly
  11.6.1 Company Details
  11.6.2 Parathyroid Disorders Product Offered
  11.6.3 Eli Lilly Parathyroid Disorders Revenue, Gross Margin and Market Share (2016-2018)
  11.6.4 Main Business Overview
  11.6.5 Eli Lilly News
11.7 Ethicon
  11.7.1 Company Details
  11.7.2 Parathyroid Disorders Product Offered
  11.7.3 Ethicon Parathyroid Disorders Revenue, Gross Margin and Market Share (2016-2018)
  11.7.4 Main Business Overview
  11.7.5 Ethicon News

...

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Table Product Specifications of Parathyroid Disorders
Figure Parathyroid Disorders Report Years Considered
Figure Market Research Methodology
Figure Global Parathyroid Disorders Market Size Growt